Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology

Transplant Proc. 2002 Sep;34(6):2259-60. doi: 10.1016/s0041-1345(02)03226-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Alanine Transaminase / blood
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Aspartate Aminotransferases / blood
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Hepatitis C / drug therapy*
  • Hepatitis C / epidemiology*
  • Hepatitis C / surgery
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use*
  • Leukopenia / chemically induced
  • Liver Function Tests
  • Liver Transplantation / immunology
  • Liver Transplantation / pathology
  • Liver Transplantation / physiology*
  • Recombinant Proteins
  • Recurrence
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use*
  • Time Factors

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin
  • Aspartate Aminotransferases
  • Alanine Transaminase